Ganga Pharmaceuticals (BOM:539680) Beta: 1.9701 (As of Jun. 28, 2026)


BOM:539680 Ganga Pharmaceuticals Ltd BOM:539680
62 GF Score
Price ₹12.00
GF Value ₹11.85
! 3 Warning Signs
View Full Analysis

What is Ganga Pharmaceuticals Beta?

Ganga Pharmaceuticals BOM:539680 62 Beta is 1.9701 as of Jun. 28, 2026. GuruFocus rates BOM:539680 with a GF Score™ of 62/100 and a GF Value™ of ₹11.85. The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Ganga Pharmaceuticals's Beta is 1.9701.


Ganga Pharmaceuticals  (BOM:539680) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Ganga Pharmaceuticals Beta Related Terms


Ganga Pharmaceuticals Beta Historical Data

* Premium members only.

The historical data trend for Ganga Pharmaceuticals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ganga Pharmaceuticals Beta Chart

Ganga Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.77 0.81 1.91 2.12

Ganga Pharmaceuticals Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 1.01 1.91 2.49 2.12

BOM:539680 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ganga Pharmaceuticals's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ganga Pharmaceuticals Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ganga Pharmaceuticals's Beta distribution charts can be found below:

* The bar in red indicates where Ganga Pharmaceuticals's Beta falls into.


BOM:539680
62GF Score
Ganga Pharmaceuticals Ltd BOM:539680
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ganga Pharmaceuticals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.9701 mean?
Ganga Pharmaceuticals (BOM:539680) has a Beta of 1.9701 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ganga Pharmaceuticals and its competitors.
Is Ganga Pharmaceuticals' Beta too high?
Ganga Pharmaceuticals' current Beta is 1.9701. Overall, Ganga Pharmaceuticals has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ganga Pharmaceuticals' Beta compare to ZTS?
Ganga Pharmaceuticals' Beta of 1.9701 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Ganga Pharmaceuticals and its competitors. Ganga Pharmaceuticals's current Beta is 1.9701. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ganga Pharmaceuticals stock overvalued right now?
Ganga Pharmaceuticals (BOM:539680) has a current Beta of 1.9701. The stock's GF Value™ is ₹11.85, compared to a current price of ₹12.00 — trading 1.3% above its estimated fair value. The current Beta is 1.9701. Ganga Pharmaceuticals' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Ganga Pharmaceuticals (BOM:539680), the current Beta is 1.9701 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ganga Pharmaceuticals (BOM:539680) Overvalued in 2026?

Based on GuruFocus' analysis, Ganga Pharmaceuticals stock appears to be overvalued. The current stock price of ₹12.00 is trading 1.3% above its estimated GF Value™ of ₹11.85.

Key valuation signals for BOM:539680:

  • Beta: 1.9701
  • GF Value™: ₹11.85 vs. price of ₹12.00 (1.3% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BOM:539680 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ganga Pharmaceuticals Business Description

Address Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.
62GF Score

Get the complete analysis for BOM:539680

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹12.00
Price
₹11.85
GF Value